10/11/2024
3:48 PM | Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
7:15 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:34 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
12:03 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
10:50 AM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
10:53 AM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:40 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/07/2024
1:48 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:28 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
1:07 PM | Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:22 PM | Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:23 PM | Ray Amrit (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:24 PM | NARACHI MICHAEL (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:25 PM | Ultragenyx Pharmaceutical (Issuer)
WELCH DANIEL G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:26 PM | Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:29 PM | Dunsire Deborah (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:22 PM | SULIMAN SHEHNAAZ (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
5:31 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
4:11 PM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5 | |
06/12/2024
6:47 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
4:10 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
4:20 PM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5 | |
06/10/2024
6:58 PM | Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
4:20 PM | Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/03/2024
2:23 PM | Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:35 PM | Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
5:06 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
7:07 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
12:41 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:39 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
11:54 AM | Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:13 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:15 PM | Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:17 PM | Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:19 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:22 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:23 PM | Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:06 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:08 PM | Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:10 PM | Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:46 AM | RTW INVESTMENTS, LP (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A | |
Here’s how to start a “Weekend Side Hustle” from your sofa (Ad) Here’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa!
It doesn't matter if you have a multi-million dollar retirement account…
Or if you’re just starting out with a few thousand.
And that’s how you can kickstart your very own “Weekend Side Hustle!”
Now that you know that… Let me show you how I target extra income as early as THIS weekend! |
02/13/2024
2:41 PM | SANDS CAPITAL MANAGEMENT, LLC (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SC 13G | |
02/08/2024
2:49 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
9:18 AM | Ultragenyx Pharmaceutical (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/29/2024
2:26 PM | BlackRock Inc. (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A | |
01/08/2024
5:03 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:17 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2023
4:22 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
4:14 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
3:47 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2023
5:31 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
5:31 AM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5 | |
10/19/2023
3:45 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2023
6:49 PM | Ultragenyx Pharmaceutical (Subject)
| Form FWP | |
10/17/2023
3:13 PM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5 | |
